# Innovative Technologies for Articular Cartilage Repair: Research, Development, and Clinical Translation—A Narrative Review

**Authors:** Adriana Lorena Lara-Bertrand, Liliana Lizarazo-Fonseca, Luz Correa-Araujo, Gustavo Salguero, Ingrid Silva-Cote

PMC · DOI: 10.3390/jfb17030128 · 2026-03-05

## TL;DR

This review explores new technologies and strategies for repairing articular cartilage, aiming to improve joint function and prevent long-term damage.

## Contribution

The paper highlights a shift toward regenerative strategies combining cells, signals, and biomimetic scaffolds for cartilage repair.

## Key findings

- Conventional surgical methods are being replaced by regenerative approaches that mimic natural cartilage structure.
- Research trends show increased focus on cell-based therapies and biomaterials for cartilage regeneration.
- Bibliometric analysis reveals growing clinical translation and intellectual property activity in the field.

## Abstract

Articular cartilage is a highly specialized connective tissue essential for joint function, providing load-bearing capacity, shock absorption, and near-frictionless motion. Due to its avascular nature, articular cartilage has a limited intrinsic healing capacity, and focal injuries often progress to degenerative joint diseases such as osteoarthritis, leading to chronic pain and functional impairment. This review examines current and emerging scientific, clinical, and technological strategies for articular cartilage repair and regeneration, with particular emphasis on their translational relevance. This narrative review integrates data from peer-reviewed literature, clinical trial registries, and patent databases. Preclinical and clinical approaches are discussed, including orthobiologics, cell-based therapies, advanced biomaterials, and three-dimensional tissue-engineered scaffolds. Bibliometric and keyword network analyses are used to identify dominant research themes, technological trends, and emerging innovations. The findings reveal a clear paradigm shift from conventional surgical interventions, often associated with fibrocartilage formation and suboptimal biomechanical performance, to multifactorial regenerative strategies combining cells, bioactive signals, and biomimetic scaffolds designed to recapitulate the native extracellular matrix. This convergence of regenerative medicine, tissue engineering, and biomaterials science is reflected in growing clinical translation efforts and intellectual property activity. Overall, although articular cartilage repair remains a significant clinical challenge, integrated regenerative approaches show great potential for achieving durable and functional cartilage regeneration.

## Linked entities

- **Diseases:** osteoarthritis (MONDO:0005178)

## Full-text entities

- **Genes:** IGF1 (insulin like growth factor 1) [NCBI Gene 3479] {aka IGF, IGF-I, IGFI, MGF}, BMP2 (bone morphogenetic protein 2) [NCBI Gene 650] {aka BDA2, BMP2A, SSFSC, SSFSC1}, Il4 (interleukin 4) [NCBI Gene 287287] {aka Il4e12}, FGF18 (fibroblast growth factor 18) [NCBI Gene 8817] {aka FGF-18, ZFGF5}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, ACAN (aggrecan) [NCBI Gene 176] {aka AGC1, AGCAN, CSPG1, CSPGCP, MSK16, SEDK}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}
- **Diseases:** pain (MESH:D010146), knee osteoarthritis (MESH:D020370), cytotoxicity (MESH:D064420), stiffness (MESH:C566112), osteoporosis (MESH:D010024), calcification (MESH:D002114), subchondral cyst (MESH:D001845), chronic pain (MESH:D059350), osteonecrosis (MESH:D010020), arthritis (MESH:D001168), joint degeneration (MESH:D009410), knee (MESH:D007718), swelling (MESH:D004487), chondral and osteochondral lesions (MESH:D010007), perforations (MESH:D057112), RA (MESH:D001172), degenerative joint diseases (MESH:D019636), OA (MESH:D010003), inflammation (MESH:D007249), joint pain (MESH:D018771), cartilage damage (MESH:D002357), Musculoskeletal Disorders (MESH:D009140), CIA (MESH:D001169), femoral condyle (MESH:D000092443), injury to (MESH:D014947), bleeding (MESH:D006470), mechanical injury (MESH:D041781), joint (MESH:D007592), loss (MESH:D016388), DTH (MESH:D006968)
- **Chemicals:** hydroxyapatite (MESH:D017886), sulfated glycosaminoglycan (MESH:C013786), chondroitin sulfate (MESH:D002809), ZnO (MESH:D015034), graphene (MESH:D006108), carbon nanotube (MESH:D037742), PLGA (MESH:D000077182), HA (MESH:D006820), calcium carbonate (MESH:D002119), lipids (MESH:D008055), PVDF (MESH:C024865), acetaminophen (MESH:D000082), ACI (-), polymer (MESH:D011108), glycosaminoglycan (MESH:D006025), PCL (MESH:C016240), poly(lactide-co-glycolide) (MESH:D011098), glycolic acid (MESH:C031149), PLA (MESH:C033616), BaTiO3 (MESH:C024547)
- **Species:** Homo sapiens (human, species) [taxon 9606], Sus scrofa (pig, species) [taxon 9823], Ovis aries (domestic sheep, species) [taxon 9940], Capra hircus (domestic goat, species) [taxon 9925], Mus musculus (house mouse, species) [taxon 10090], Oryctolagus cuniculus (domestic rabbit, species) [taxon 9986], Rattus norvegicus (brown rat, species) [taxon 10116]

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13027012/full.md

---
Source: https://tomesphere.com/paper/PMC13027012